Rambus Inc. (NASDAQ:RMBS) Expected to Post Earnings of $0.20 Per Share

Share on StockTwits

Wall Street brokerages expect Rambus Inc. (NASDAQ:RMBS) to post earnings of $0.20 per share for the current fiscal quarter, Zacks Investment Research reports. Four analysts have made estimates for Rambus’ earnings, with the lowest EPS estimate coming in at $0.20 and the highest estimate coming in at $0.21. Rambus reported earnings of $0.21 per share in the same quarter last year, which would indicate a negative year-over-year growth rate of 4.8%. The firm is scheduled to report its next earnings results after the market closes on Monday, July 29th.

According to Zacks, analysts expect that Rambus will report full year earnings of $0.91 per share for the current year, with EPS estimates ranging from $0.90 to $0.94. For the next financial year, analysts anticipate that the business will report earnings of $0.95 per share, with EPS estimates ranging from $0.93 to $0.98. Zacks’ earnings per share calculations are an average based on a survey of analysts that cover Rambus.

Rambus (NASDAQ:RMBS) last posted its quarterly earnings results on Monday, April 22nd. The semiconductor company reported ($0.13) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.23 by ($0.36). Rambus had a positive return on equity of 5.11% and a negative net margin of 25.04%. The company had revenue of $100.20 million for the quarter, compared to analyst estimates of $99.00 million. During the same period last year, the company earned $0.21 earnings per share. The business’s revenue for the quarter was down .3% compared to the same quarter last year.

RMBS has been the topic of a number of recent analyst reports. Deutsche Bank set a $137.00 price target on shares of Verisk Analytics and gave the stock a “hold” rating in a research note on Tuesday, April 23rd. TheStreet raised shares of Wayside Technology Group from a “c” rating to a “b-” rating in a research note on Friday, April 12th. BidaskClub cut shares of ZIX from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, May 21st. Wells Fargo & Co initiated coverage on shares of Semtech in a research note on Tuesday, May 14th. They set an “outperform” rating and a $48.03 price target on the stock. Finally, Zacks Investment Research cut shares of Hancock Jaffe Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, June 26th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $12.09.

Shares of NASDAQ:RMBS traded up $0.15 on Friday, reaching $12.53. 592,127 shares of the company were exchanged, compared to its average volume of 415,767. The company has a current ratio of 7.87, a quick ratio of 7.75 and a debt-to-equity ratio of 0.16. Rambus has a 1-year low of $7.17 and a 1-year high of $13.61. The company has a market capitalization of $1.37 billion, a price-to-earnings ratio of 16.49, a price-to-earnings-growth ratio of 1.69 and a beta of 0.75. The stock’s 50-day simple moving average is $11.86.

In related news, insider Luc Seraphin sold 18,287 shares of the business’s stock in a transaction dated Wednesday, July 3rd. The shares were sold at an average price of $11.98, for a total value of $219,078.26. Following the sale, the insider now directly owns 228,697 shares in the company, valued at approximately $2,739,790.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Charles Kissner sold 3,723 shares of the business’s stock in a transaction dated Tuesday, July 2nd. The stock was sold at an average price of $12.08, for a total transaction of $44,973.84. Following the completion of the sale, the director now owns 47,503 shares in the company, valued at $573,836.24. The disclosure for this sale can be found here. Insiders sold a total of 25,434 shares of company stock worth $303,078 over the last quarter. Insiders own 1.00% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in RMBS. Norges Bank purchased a new position in Rambus in the 4th quarter valued at about $13,318,000. Vaughan Nelson Investment Management L.P. purchased a new position in Rambus in the 1st quarter valued at about $16,601,000. Assenagon Asset Management S.A. lifted its holdings in Rambus by 573.2% in the 1st quarter. Assenagon Asset Management S.A. now owns 554,217 shares of the semiconductor company’s stock valued at $5,792,000 after purchasing an additional 471,886 shares in the last quarter. Two Sigma Investments LP lifted its holdings in Rambus by 245.2% in the 4th quarter. Two Sigma Investments LP now owns 550,375 shares of the semiconductor company’s stock valued at $4,221,000 after purchasing an additional 390,947 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Rambus by 6.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 5,909,106 shares of the semiconductor company’s stock valued at $45,323,000 after purchasing an additional 333,048 shares in the last quarter. Institutional investors own 77.84% of the company’s stock.

Rambus Company Profile

Rambus Inc provides semiconductor products in the United States, Japan, Europe, Taiwan, China, South Korea, Canada, Singapore, Asia, and internationally. The company operates through three divisions: Memory and Interfaces, Rambus Security, and Emerging Solutions. The Memory and Interfaces division engages in the design, development, and manufacturing through partnerships and licensing of technology and solutions related to memory and interfaces.

Read More: What are popular green investing opportunities?

Get a free copy of the Zacks research report on Rambus (RMBS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Rambus (NASDAQ:RMBS)

Receive News & Ratings for Rambus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rambus and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.